Not applicableEnded earlyNCT00161239What this trial is testingLAMPP Trial for Peripheral and Cutaneous T-Cell LymphomaWho this might be right forT-Cell Lymphoma University of Medicine and Dentistry of New Jersey 64
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)UnknownNCT04712864What this trial is testingStudy of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell LymphomaWho this might be right forT-Cell LymphomaPeripheral T-Cell Lymphoma RefractoryCutaneous T-Cell Lymphoma Refractory+2 more Legend Biotech USA Inc 50
Early research (Phase 1)UnknownNCT01645293What this trial is testingMulticentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis FungoidesWho this might be right forCD30 Positive Cutaneous T Cell LymphomaCD30 Positive Transformed Mycosis Fungoides University of Cologne 15
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT00049712What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific University of Wisconsin, Madison
Post-approval studies (Phase 4)Study completedNCT00211198What this trial is testingStudy of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)Who this might be right forLymphoma, T-Cell, Cutaneous Eisai Inc. 60
Not applicableWithdrawnNCT01558778What this trial is testingMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more Roswell Park Cancer Institute
Early research (Phase 1)Ended earlyNCT00004058What this trial is testing12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow DisorderWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT00030849What this trial is testingBexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Not applicableNot Yet RecruitingNCT07046663What this trial is testingLong-term Assessment of Chlormethine Gel in Mycosis FungoidesWho this might be right forCutaneous T-Cell Lymphoma/Mycosis Fungoides Fondazione Italiana Linfomi - ETS 190
Large-scale testing (Phase 3)Study completedNCT00003687What this trial is testingTreatment for Chronic Pain in Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more NCIC Clinical Trials Group 87
Testing effectiveness (Phase 2)Study completedNCT00182637What this trial is testingBortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell LymphomaWho this might be right forLymphoma Jonsson Comprehensive Cancer Center 5
Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic
Large-scale testing (Phase 3)Temporarily pausedNCT04799275What this trial is testingTesting CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell LymphomaWho this might be right forAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IIX (Bulky) Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma+18 more National Cancer Institute (NCI) 422
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Not applicableStudy completedNCT06113081What this trial is testingReal World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell LymphomaWho this might be right forCutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome Fondazione Italiana Linfomi - ETS 100
Testing effectiveness (Phase 2)Looking for participantsNCT06810778What this trial is testingDuvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Who this might be right forT-cell-prolymphocytic LeukemiaCutaneous T-Cell Lymphoma Refractory Jonsson Comprehensive Cancer Center 12
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00002635What this trial is testingAminocamptothecin in Treating Patients With T-cell LymphomaWho this might be right forLymphoma Yale University 12